Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Home/Insights/Research trends in microvascular mechanism

Research trends in microvascular mechanism

Coronary microvascular dysfunction moved from a diagnosis of exclusion to a recognised disease entity — and most of those affected are women.

Microcirculation and microvascular function

The clinical problem

A substantial proportion of patients with angina have no obstructive coronary artery disease on angiography. Historically they were reassured and discharged. It is now established that many have coronary microvascular dysfunction or vasospasm, that their symptoms have a physiological basis, and that their prognosis is not benign.

The terms INOCA (ischaemia with no obstructive coronary arteries) and ANOCA (angina with no obstructive coronary arteries) name this population. Women are over-represented, which is part of why the condition was under-recognised for so long.

Measurement

Invasive coronary function testing measures coronary flow reserve and the index of microcirculatory resistance, and provocation testing identifies vasospasm. These are the reference methods and distinguish the endotypes, which matters because treatment differs between them.

Non-invasive assessment is possible with stress perfusion CMR, PET-derived myocardial blood flow and some echocardiographic methods. Thresholds differ between modalities and are not interchangeable.

Why endotype matters

Structural microvascular dysfunction, functional dysfunction and epicardial vasospasm respond to different treatment. Managing all INOCA identically is the main reason earlier therapeutic studies were unconvincing, and stratified management is the direction the field has taken.

Beyond the coronary circulation

Microvascular dysfunction is implicated in heart failure with preserved ejection fraction, in diabetes, in chronic kidney disease and in cerebral small vessel disease, with shared endothelial mechanisms. Whether these represent one systemic process is an active question.

Reporting

State the method and threshold used to define dysfunction, since definitions vary. Report sex-disaggregated results — in this area aggregate results conceal the principal finding.

In short

What to take from this.

  • INOCA is not a benign diagnosis of exclusion.
  • Endotype determines treatment; do not pool them.
  • Report sex-disaggregated results in this field.

Sources

  • Established literature on coronary microvascular dysfunction and INOCA
  • Consensus documents on invasive coronary function testing

This page reflects established understanding as at mid-2026 and is not a current-awareness service. Clinical and regulatory positions change; verify anything decision-relevant against a current source.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.